Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202865
Status:
COMPLETED
Last Update Posted:
2017-03-24
First Post:
2005-09-16
Brief Title:
Evaluation of Low Dose Infliximab in Ankylosing Spondylitis Study P04352
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
CANaDian Evaluation of Low DosE Infliximab in Ankylosing Spondylitis
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CANDLE
Brief Summary:
This is a randomized double-blind multi-center placebo-controlled study with two parallel treatment groups placebo and infliximab in subjects with ankylosing spondylitis AS to evaluate the efficacy of infliximab 3 mgkg
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2472 | None | None | None |